chr19-18177228-A-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_006332.5(IFI30):āc.572A>Cā(p.Asn191Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000056 in 1,588,748 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000046 ( 1 hom., cov: 31)
Exomes š: 0.000057 ( 0 hom. )
Consequence
IFI30
NM_006332.5 missense
NM_006332.5 missense
Scores
4
4
11
Clinical Significance
Conservation
PhyloP100: 7.85
Genes affected
IFI30 (HGNC:5398): (IFI30 lysosomal thiol reductase) The protein encoded by this gene is a lysosomal thiol reductase that at low pH can reduce protein disulfide bonds. The enzyme is expressed constitutively in antigen-presenting cells and induced by gamma-interferon in other cell types. This enzyme has an important role in MHC class II-restricted antigen processing. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.37492698).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFI30 | NM_006332.5 | c.572A>C | p.Asn191Thr | missense_variant | 5/7 | ENST00000407280.4 | NP_006323.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFI30 | ENST00000407280.4 | c.572A>C | p.Asn191Thr | missense_variant | 5/7 | 1 | NM_006332.5 | ENSP00000384886.1 | ||
ENSG00000268173 | ENST00000593731.1 | n.*2008A>C | non_coding_transcript_exon_variant | 23/25 | 2 | ENSP00000471914.1 | ||||
ENSG00000268173 | ENST00000593731.1 | n.*2008A>C | 3_prime_UTR_variant | 23/25 | 2 | ENSP00000471914.1 | ||||
IFI30 | ENST00000600463.1 | n.1311A>C | non_coding_transcript_exon_variant | 4/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152208Hom.: 1 Cov.: 31
GnomAD3 genomes
AF:
AC:
7
AN:
152208
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000162 AC: 34AN: 209248Hom.: 0 AF XY: 0.000195 AC XY: 22AN XY: 112760
GnomAD3 exomes
AF:
AC:
34
AN:
209248
Hom.:
AF XY:
AC XY:
22
AN XY:
112760
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000571 AC: 82AN: 1436422Hom.: 0 Cov.: 34 AF XY: 0.0000786 AC XY: 56AN XY: 712048
GnomAD4 exome
AF:
AC:
82
AN:
1436422
Hom.:
Cov.:
34
AF XY:
AC XY:
56
AN XY:
712048
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152326Hom.: 1 Cov.: 31 AF XY: 0.0000671 AC XY: 5AN XY: 74496
GnomAD4 genome
AF:
AC:
7
AN:
152326
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
20
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 05, 2023 | The c.572A>C (p.N191T) alteration is located in exon 5 (coding exon 5) of the IFI30 gene. This alteration results from a A to C substitution at nucleotide position 572, causing the asparagine (N) at amino acid position 191 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Uncertain
D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
P
Vest4
MutPred
Gain of phosphorylation at N191 (P = 0.0467);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at